Michel van Harten, MD, is the visionary CEO at the helm of myTomorrows, a health technology company which has developed a next-generation AI platform to streamline clinical trial recruitment, breaking down barriers for patients seeking treatment options. Its unique and proprietary technology conducts a comprehensive and accurate search of clinical trials from global public registries, efficiently connecting patients, physicians, trial sites and BioPharma to simplify and accelerate access to drugs in development.
Michel earned both his BSc in Economics and his Medical Degree at the University of Amsterdam. He worked as a physician at the Antoni van Leeuwenhoek Hospital, a specialized cancer hospital and research institute in the Department of Surgical Oncology. As a physician, with more than 15 years of experience in the healthcare and pharma industry, Michel possesses a deep understanding of the challenges that patients and healthcare providers face."
